BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, June 11, 2026
Home » Authors » Anette Breindl

Anette Breindl

Articles

ARTICLES

Small molecules allow CRISPR to show its constructive side

Feb. 9, 2015
By Anette Breindl
CRISPR/Cas9 has generated much excitement as a genome editing technology that is simple enough for very widespread use.
Read More

Inflammation can be helpful in Alzheimer's disease, research shows

Feb. 6, 2015
By Anette Breindl
Two separate research teams have shown that the cytokine interleukin-10 (IL-10) plays a role in Alzheimer's disease – but not like most people would expect. In animal studies, despite its anti-inflammatory properties, IL-10 seemed to make things worse as far as both plaque formation and cognition were concerned.
Read More

Mice lacking RGS6 protein want less alcohol, and tolerate more of it

Feb. 3, 2015
By Anette Breindl
For treating alcohol dependence and its consequences, an ounce of prevention and a pound of cure might be achieved by targeting the same protein: regulator of G protein 6 (RGS6).
Read More

Myc-y mouse: The oldest, happiest mouse on earth

Jan. 23, 2015
By Anette Breindl
The transcription factor Myc plays a major role in gene expression. It regulates the expression of 15 percent to 20 percent of all genes, and Myc mutations are known or suspected to be drivers in many cancers. As a result, there is a very active, if to date unsuccessful, push by the biopharma industry to develop Myc gene inhibitors.
Read More

Synthetic biology used for biocontainment

Jan. 22, 2015
By Anette Breindl
Two independent research teams have engineered microorganisms that are dependent on synthetic amino acids for their survival, making them unable to grow without a constant supply of synthetic nutrients.
Read More

Detailed atlas of variants for heart disease gene, protein give new insights

Jan. 15, 2015
By Anette Breindl
Through large-scale sequencing and screening, researchers have gained new insights into the role – and sometimes the lack of a role – of the protein titin in heart disease.
Read More

Ebola vaccines: Both a sprint and a marathon

Jan. 14, 2015
By Anette Breindl
Last week, policymakers, researchers and vaccine developers met at the World Health Organization (WHO) headquarters to review the landscape of current and upcoming Ebola vaccine clinical trials. Their goal, in the words of Director-General Margaret Chan, was to "take stock, plan the next steps and make sure that all partners are working in tandem."
Read More

Hyperactive bladder drug activates metabolism

Jan. 14, 2015
By Anette Breindl
Myrbetriq (mirabegron, Astellas Pharma Inc.), which is approved for the treatment of overactive bladder, may find itself useful in another indication. In a phase I trial, the drug activated brown fat and increased the metabolic rate of healthy male volunteers.
Read More

It's Complicated: Genome studies broaden and deepen as methods progress

Jan. 12, 2015
By Anette Breindl

Ebola vaccines: Both a sprint and a marathon

Jan. 12, 2015
By Anette Breindl
Last week, policy-makers, researchers and vaccine developers met at the World Health Organization (WHO) headquarters to review the landscape of current and upcoming Ebola vaccine clinical trials.
Read More
View All Articles by Anette Breindl

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 10, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 9, 2026
  • 3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

    Skape Bio unlocks GPCR targets with de novo-designed miniproteins

    BioWorld
    Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
  • Wuxi Apptec signage

    Wuxi Apptec insists it’s ‘not a Chinese military company’

    BioWorld
    Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
  • Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors

    BioWorld Science
    Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing